The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs.
Related stories
Chip stocks fall as oil prices gain, Treasury yields stay elevated: AlphaCheck
Here’s how to prepare your portfolio for the Fed’s next interest-rate moves
Dominion, NextEra propose $1 billion-a-year Virginia supplier program
US Pentagon triggers alarm for 150M+ American drivers after massive ID breach — is your identity exposed? Do this now
Costco rations Kirkland motor oil, raises price to $57.99
Clear Secure Chief Accounting Officer Sells 6,059 Shares